• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在具有α-微管蛋白突变的紫杉醇耐药/依赖A549细胞系中微管解聚因子水平升高。

Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation.

作者信息

Martello Laura A, Verdier-Pinard Pascal, Shen Heng-Jia, He Lifeng, Torres Keila, Orr George A, Horwitz Susan Band

机构信息

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

出版信息

Cancer Res. 2003 Mar 15;63(6):1207-13.

PMID:12649178
Abstract

The A549 Taxol-resistant cell lines, A549-T12 and A549-T24, were isolated in our laboratory, and are dependent on Taxol for normal growth. The microtubules in these cells displayed increased dynamicity in the absence of Taxol. In the present study, a heterozygous point mutation in Kalpha1-tubulin was discovered at alpha379 (Ser to Ser/Arg). Although Taxol binds to beta-tubulin in the microtubule, sequencing of beta-tubulin class I did not reveal any mutations. The expression of the alpha-tubulin mutation was demonstrated using high-resolution isoelectric focusing and two-dimensional gel analysis. Both the wild-type and mutant tubulin were expressed in the Taxol-resistant cell lines. The region of alpha-tubulin that encompasses alpha379 is near the COOH terminus that has been proposed as a site of interaction with microtubule-associated protein (MAP) 4 and stathmin, a tubulin-interacting protein. In the Taxol-resistant cells, the active nonphosphorylated form of stathmin was increased approximately 2-fold, whereas the inactive phosphorylated forms were barely detected. The inactive phosphorylated forms of MAP4 were increased in the A549-T12 and A549-T24 cell lines. We hypothesize that these changes in tubulin/MAPs that result in increased microtubule instability may be related to the alpha-tubulin mutation and are compensated for by the stabilizing properties of Taxol.

摘要

A549紫杉醇耐药细胞系A549-T12和A549-T24是在我们实验室分离得到的,其正常生长依赖于紫杉醇。在没有紫杉醇的情况下,这些细胞中的微管表现出更高的动态性。在本研究中,在Kalpha1-微管蛋白的alpha379位点(丝氨酸突变为丝氨酸/精氨酸)发现了一个杂合点突变。尽管紫杉醇与微管中的β-微管蛋白结合,但对I类β-微管蛋白进行测序未发现任何突变。使用高分辨率等电聚焦和二维凝胶分析证实了α-微管蛋白突变的表达。野生型和突变型微管蛋白均在紫杉醇耐药细胞系中表达。包含alpha379的α-微管蛋白区域靠近COOH末端,该末端被认为是与微管相关蛋白(MAP)4和微管相互作用蛋白stathmin相互作用的位点。在紫杉醇耐药细胞中,stathmin的活性非磷酸化形式增加了约2倍,而无活性的磷酸化形式几乎检测不到。在A549-T12和A549-T24细胞系中,MAP4的无活性磷酸化形式增加。我们推测,这些导致微管不稳定性增加的微管蛋白/MAPs变化可能与α-微管蛋白突变有关,并由紫杉醇的稳定特性所补偿。

相似文献

1
Elevated levels of microtubule destabilizing factors in a Taxol-resistant/dependent A549 cell line with an alpha-tubulin mutation.在具有α-微管蛋白突变的紫杉醇耐药/依赖A549细胞系中微管解聚因子水平升高。
Cancer Res. 2003 Mar 15;63(6):1207-13.
2
A highly epothilone B-resistant A549 cell line with mutations in tubulin that confer drug dependence.一种对埃坡霉素B具有高度抗性的A549细胞系,其微管蛋白发生突变,导致对药物产生依赖性。
Mol Cancer Ther. 2005 Jun;4(6):987-95. doi: 10.1158/1535-7163.MCT-05-0024.
3
Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry.通过等电聚焦和质谱联用分析紫杉醇耐药细胞中的微管蛋白亚型和突变
Biochemistry. 2003 May 13;42(18):5349-57. doi: 10.1021/bi027293o.
4
Mutations in beta-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines.β-微管蛋白中的突变定位于参与埃坡霉素抗性细胞系中微管稳定性调节的结构域。
Mol Cancer Ther. 2001 Nov;1(1):3-10.
5
Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics.肺癌细胞中对紫杉醇的耐药性与微管动力学增加有关。
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11737-42. doi: 10.1073/pnas.191388598. Epub 2001 Sep 18.
6
Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells.多种微管改变与人类白血病细胞对长春花生物碱的耐药性相关。
Cancer Res. 2001 Aug 1;61(15):5803-9.
7
Wild-type class I beta-tubulin sensitizes Taxol-resistant breast adenocarcinoma cells harboring a beta-tubulin mutation.野生型I类β-微管蛋白使携带β-微管蛋白突变的耐紫杉醇乳腺腺癌细胞敏感化。
Cancer Lett. 2007 Nov 18;257(2):227-35. doi: 10.1016/j.canlet.2007.07.022. Epub 2007 Sep 14.
8
Neuronal-associated microtubule proteins class III beta-tubulin and MAP2c in neuroblastoma: role in resistance to microtubule-targeted drugs.神经母细胞瘤中与神经元相关的微管蛋白III类β-微管蛋白和MAP2c:在对微管靶向药物耐药中的作用
Mol Cancer Ther. 2004 Sep;3(9):1137-46.
9
Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.对紫杉醇耐药的上皮性卵巢肿瘤与特定β-微管蛋白亚型的表达改变有关。
J Clin Invest. 1997 Sep 1;100(5):1282-93. doi: 10.1172/JCI119642.
10
Antisense oligonucleotides to class III beta-tubulin sensitize drug-resistant cells to Taxol.针对III类β-微管蛋白的反义寡核苷酸使耐药细胞对紫杉醇敏感。
Br J Cancer. 1999 Jun;80(7):1020-5. doi: 10.1038/sj.bjc.6690507.

引用本文的文献

1
Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells.肌动蛋白异构体失衡促进紫杉醇耐药三阴性乳腺癌细胞的肿瘤进展。
Int J Mol Sci. 2024 Apr 20;25(8):4530. doi: 10.3390/ijms25084530.
2
Understanding molecular mechanisms and predicting phenotypic effects of pathogenic tubulin mutations.理解致病微管蛋白突变的分子机制和预测表型效应。
PLoS Comput Biol. 2022 Oct 7;18(10):e1010611. doi: 10.1371/journal.pcbi.1010611. eCollection 2022 Oct.
3
PI3K/AKT Signaling Tips the Balance of Cytoskeletal Forces for Cancer Progression.
PI3K/AKT信号传导影响细胞骨架力平衡以促进癌症进展。
Cancers (Basel). 2022 Mar 24;14(7):1652. doi: 10.3390/cancers14071652.
4
Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers.基于纳米技术的药物递送与靶向治疗以克服卵巢癌的耐药性
Cancers (Basel). 2021 Oct 31;13(21):5480. doi: 10.3390/cancers13215480.
5
Mdivi-1 induces spindle abnormalities and augments taxol cytotoxicity in MDA-MB-231 cells.Mdivi-1可诱导MDA-MB-231细胞出现纺锤体异常并增强紫杉醇的细胞毒性。
Cell Death Discov. 2021 May 20;7(1):118. doi: 10.1038/s41420-021-00495-z.
6
CTCs-oriented adjuvant personalized cytostatic therapy non-metastatic breast cancer patients: continuous non-randomized prospective study and prospective randomized controlled study.以循环肿瘤细胞为导向的辅助个性化细胞毒化疗用于非转移性乳腺癌患者:连续非随机前瞻性研究和前瞻性随机对照研究。
Breast Cancer Res Treat. 2021 Apr;186(2):439-451. doi: 10.1007/s10549-020-06036-z. Epub 2021 Jan 3.
7
Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer.口服微管蛋白抑制剂 VERU-111 增强紫杉醇耐药肺癌的抗肿瘤疗效。
Cancer Lett. 2020 Dec 28;495:76-88. doi: 10.1016/j.canlet.2020.09.004. Epub 2020 Sep 11.
8
Cytoskeletal Proteins in Cancer and Intracellular Stress: A Therapeutic Perspective.癌症与细胞内应激中的细胞骨架蛋白:治疗前景
Cancers (Basel). 2020 Jan 18;12(1):238. doi: 10.3390/cancers12010238.
9
SAC3D1: a novel prognostic marker in hepatocellular carcinoma.SAC3D1:肝细胞癌的一种新型预后标志物。
Sci Rep. 2018 Oct 23;8(1):15608. doi: 10.1038/s41598-018-34129-9.
10
Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.通过调节 FER 介导的 CRMP2 磷酸化来调节微管动力学以增强癌症治疗。
Nat Commun. 2018 Feb 2;9(1):476. doi: 10.1038/s41467-017-02811-7.